Publications

Detailed Information

Association between blood lead levels (< 5 mu g/dL) and inattention-hyperactivity and neurocognitive profiles in school-aged Korean children

DC Field Value Language
dc.contributor.authorKim, Yeni-
dc.contributor.authorCho, Soo-Churl-
dc.contributor.authorKim, Bung-Nyun-
dc.contributor.authorHong, Yun-Chul-
dc.contributor.authorYoo, Hee-Jeong-
dc.contributor.authorBhang, Soo-Young-
dc.contributor.authorKim, Jae-Won-
dc.contributor.authorShin, Min-Sup-
dc.date.accessioned2012-06-07T07:33:28Z-
dc.date.available2012-06-07T07:33:28Z-
dc.date.issued2010-11-01-
dc.identifier.citationSCIENCE OF THE TOTAL ENVIRONMENT; Vol.408 23; 5737-5743ko_KR
dc.identifier.issn0048-9697-
dc.identifier.urihttps://hdl.handle.net/10371/76876-
dc.description.abstractObjectives The association between low blood lead levels (<5 mu g/dL) and the inattention-hyperactivity symptoms and neurocognitive profiles of school-aged Korean children was investigated Methods We measured blood lead levels in 256 Korean children aged 8-10 years Teachers completed the Attention-Deficit Hyperactivity Disorder Rating Scale (T-ARS)-IV to assess inattentive and hyperactive symptoms. Parents completed the Korean version of the Learning Disability Evaluation Scale (K-LDES) Children performed neurocognitive tests [The Continuous Performance Test (CPT) the Children`s Color Trails Test, and the Stroop Color and Word Test (SCWT)] Results. A linear regression analysis indicated that the blood lead concentrations were associated with the inattention scores [B = 48, SE = 1 6.95% confidence interval (Cl): 15-80], the hyperactivity subscores (3.1, 1 4, 0 3-5.9), and the total score (7.9, 29, 2.1-13.6) on the T-ARS, the number of omission errors on the CPT (20 6, 7 1, 6 5-34 6), the listening (-1.4, 07, -2.8 to -0.1), reading (-21, 07, -3.4 to -0.7), writing (-20, 07, -34 to -0.6), spelling (-22, 07, -37 to -07). and calculating (-1 8, 07, -3 1 to -0.4) scores on the K-LDES, and the color-word score on the SCWT (-67, 34, -13.3 to -01) A logistic regression analysis indicated that the probability of inattentive and hyperactive symptoms was increased with higher blood lead levels in boys with an odds ratio of 2 768 [B= 1 018. S E. = 0 487, p = 0 036. 95% CI: 1 066-7.187] Conclusion This study suggests that even low blood lead levels (<51 mu g/dL) are associated with inattentive and hyperactivity symptoms and learning difficulties in school-aged children (C) 2010 Elsevier BV All rights reservedko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE BVko_KR
dc.subjectChildrenko_KR
dc.subjectInattentionko_KR
dc.subjectHyperactivityko_KR
dc.subjectLearningko_KR
dc.subjectLeadko_KR
dc.titleAssociation between blood lead levels (< 5 mu g/dL) and inattention-hyperactivity and neurocognitive profiles in school-aged Korean childrenko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김예니-
dc.contributor.AlternativeAuthor조수철-
dc.contributor.AlternativeAuthor김병연-
dc.contributor.AlternativeAuthor홍윤철-
dc.contributor.AlternativeAuthor신민섭-
dc.contributor.AlternativeAuthor유희정-
dc.contributor.AlternativeAuthor김재원-
dc.contributor.AlternativeAuthor방수영-
dc.identifier.doi10.1016/j.scitotenv.2010.07.070-
dc.citation.journaltitleSCIENCE OF THE TOTAL ENVIRONMENT-
dc.description.citedreferenceNigg JT, 2010, J CHILD PSYCHOL PSYC, V51, P58, DOI 10.1111/j.1469-7610.2009.02135.x-
dc.description.citedreferenceFroehlich TE, 2009, PEDIATRICS, V124, pE1054, DOI 10.1542/peds.2009-0738-
dc.description.citedreferenceRoy A, 2009, ENVIRON HEALTH PERSP, V117, P1607, DOI 10.1289/ehp.0900625-
dc.description.citedreferenceKim Y, 2009, NEUROTOXICOLOGY, V30, P564, DOI 10.1016/j.neuro.2009.03.012-
dc.description.citedreferenceWallis D, 2008, J PEDIATR PSYCHOL, V33, P1085, DOI 10.1093/jpepsy/jsn049-
dc.description.citedreferenceWang HL, 2008, ENVIRON HEALTH PERSP, V116, P1401, DOI 10.1289/ehp.11400-
dc.description.citedreferenceNigg JT, 2008, BIOL PSYCHIAT, V63, P325, DOI 10.1016/j.biopsych.2007.07.013-
dc.description.citedreferenceMillichap JG, 2008, PEDIATRICS, V121, pE358, DOI 10.1542/peds.2007-1332-
dc.description.citedreferenceKOO HJ, 2008, J KOR ACAD CHILD ADO, P29-
dc.description.citedreferenceFroehlich TE, 2007, ARCH PEDIAT ADOL MED, V161, P857-
dc.description.citedreferenceChiodo LM, 2007, NEUROTOXICOL TERATOL, V29, P538, DOI 10.1016/j.ntt.2007.04.001-
dc.description.citedreferenceFinkelstein Y, 2007, NEUROTOXICOLOGY, V28, P1003, DOI 10.1016/j.neuro.2007.08.006-
dc.description.citedreferenceSwanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9-
dc.description.citedreferenceBANERJEE TD, 2007, ACTA PAEDIATR, V96, P1269-
dc.description.citedreferenceSHIN MS, 2007, STROOP COLOR WORD TE-
dc.description.citedreferenceBraun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478-
dc.description.citedreferenceKHAN SA, 2006, CURR PSYCHIAT REP, V8, P393-
dc.description.citedreferenceBiederman J, 2005, LANCET, V366, P237-
dc.description.citedreferenceLanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688-
dc.description.citedreferenceRemschmidt H, 2005, EUR CHILD ADOLES PSY, V14, P127, DOI 10.1007/s00787-005-0439-x-
dc.description.citedreferenceRis MD, 2004, J INT NEUROPSYCH SOC, V10, P261, DOI 10.1017/S1355617704102154-
dc.description.citedreferenceCanfield RL, 2004, DEV NEUROPSYCHOL, V26, P513-
dc.description.citedreferenceCostello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837-
dc.description.citedreferenceLesesne CA, 2003, PEDIATRICS, V111, P1232-
dc.description.citedreferenceLidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014-
dc.description.citedreferenceKIM YS, 2003, J KOREAN NEUROPSYCHI, V42, P352-
dc.description.citedreferenceSO YK, 2002, J KOREAN NEUROPSYCHI, V41, P283-
dc.description.citedreferenceErnst M, 2001, J AM ACAD CHILD PSY, V40, P630-
dc.description.citedreferenceLeibson CL, 2001, JAMA-J AM MED ASSOC, V285, P60-
dc.description.citedreference*AM PSYCH ASS, 2000, AM DIAGN STAT MAN ME-
dc.description.citedreferenceSHIN MS, 2000, J KOR ACAD CHILD ADO, P91-
dc.description.citedreferenceWeissman MM, 1999, J AM ACAD CHILD PSY, V38, P892-
dc.description.citedreferenceBurns JM, 1999, AM J EPIDEMIOL, V149, P740-
dc.description.citedreferenceBressler J, 1999, NEUROCHEM RES, V24, P595-
dc.description.citedreferenceConners CK, 1998, J ABNORM CHILD PSYCH, V26, P257-
dc.description.citedreferenceZheng W, 1998, BRAIN RES, V799, P334-
dc.description.citedreferenceMendelsohn AL, 1998, PEDIATRICS, V101-
dc.description.citedreferenceDuPaul GJ, 1998, J PSYCHOEDUC ASSESS, V16, P55-
dc.description.citedreferenceSHIN MS, 1998, J KOREAN NEUROPSYCHI, V37, P1233-
dc.description.citedreferenceDELIA L, 1996, COLOR TRAILS TEST PR-
dc.description.citedreferenceFERGUSSON DM, 1993, J CHILD PSYCHOL PSYC, V34, P215-
dc.description.citedreferenceLEVITON A, 1993, ENVIRON RES, V60, P30-
dc.description.citedreferenceLYNGBYE T, 1990, ACTA PAEDIATR SCAND, V79, P352-
dc.description.citedreferenceTHOMSON GOB, 1989, J CHILD PSYCHOL PSYC, V30, P515-
dc.description.citedreferenceSILVA PA, 1988, J CHILD PSYCHOL PSYC, V29, P43-
dc.description.citedreferenceMCCARNEY SB, 1983, LEARNING DISABILITY-
dc.description.citedreferenceNEEDLEMAN HL, 1979, NEW ENGL J MED, V300, P689-
dc.description.citedreferenceGORDON CJ, 1975, J PERS ASSESS, V39, P386-
dc.description.citedreferenceByers RK, 1943, AM J DIS CHILD, V66, P471-
dc.description.tc1-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share